
MO19390 (SAiL): Bleeding events in a phase IV study of first-line bevacizumab with chemotherapy in patients with advanced non-squamous NSCLC
Keywords: بواسیزوماب; Bevacizumab; Non-small cell lung cancer; Chemotherapy; Phase IV; Safety;